237 related articles for article (PubMed ID: 27438594)
1. Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Wang L; Chopp M; Szalad A; Lu X; Jia L; Lu M; Zhang RL; Zhang ZG
PLoS One; 2016; 11(7):e0159665. PubMed ID: 27438594
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice.
Wang L; Chopp M; Szalad A; Jia L; Lu X; Lu M; Zhang L; Zhang Y; Zhang R; Zhang ZG
PLoS One; 2015; 10(2):e0118134. PubMed ID: 25689401
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.
Wang L; Chopp M; Szalad A; Liu Z; Bolz M; Alvarez FM; Lu M; Zhang L; Cui Y; Zhang RL; Zhang ZG
Neuroscience; 2011 Oct; 193():399-410. PubMed ID: 21820491
[TBL] [Abstract][Full Text] [Related]
4. Protection of insulin‑like growth factor 1 on experimental peripheral neuropathy in diabetic mice.
Wang H; Zhang H; Cao F; Lu J; Tang J; Li H; Zhang Y; Feng B; Tang Z
Mol Med Rep; 2018 Nov; 18(5):4577-4586. PubMed ID: 30221656
[TBL] [Abstract][Full Text] [Related]
5. miR-146a mediates thymosin β4 induced neurovascular remodeling of diabetic peripheral neuropathy in type-II diabetic mice.
Wang L; Chopp M; Lu X; Szalad A; Jia L; Liu XS; Wu KH; Lu M; Zhang ZG
Brain Res; 2019 Mar; 1707():198-207. PubMed ID: 30500399
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy.
Wang L; Chopp M; Jia L; Lu X; Szalad A; Zhang Y; Zhang R; Zhang ZG
J Diabetes Res; 2015; 2015():173656. PubMed ID: 25945352
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-1/Tie2 signaling pathway contributes to the therapeutic effect of thymosin β4 on diabetic peripheral neuropathy.
Wang L; Chopp M; Szalad A; Lu X; Lu M; Zhang T; Zhang ZG
Neurosci Res; 2019 Oct; 147():1-8. PubMed ID: 30326249
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.
Samii A; Unger J; Lange W
Neurosci Lett; 1999 Mar; 262(3):159-62. PubMed ID: 10218880
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice.
Wang L; Chopp M; Szalad A; Liu Z; Lu M; Zhang L; Zhang J; Zhang RL; Morris D; Zhang ZG
Neurobiol Dis; 2012 Dec; 48(3):546-55. PubMed ID: 22922221
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes.
Fan B; Li C; Szalad A; Wang L; Pan W; Zhang R; Chopp M; Zhang ZG; Liu XS
Diabetologia; 2020 Feb; 63(2):431-443. PubMed ID: 31740984
[TBL] [Abstract][Full Text] [Related]
11. Magnolol effectively ameliorates diabetic peripheral neuropathy in mice.
Yang J; Wei Y; Zhao T; Li X; Zhao X; Ouyang X; Zhou L; Zhan X; Qian M; Wang J; Shen X
Phytomedicine; 2022 Dec; 107():154434. PubMed ID: 36122436
[TBL] [Abstract][Full Text] [Related]
12. Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats.
Li R; Zhang J; Zhang L; Cui Q; Liu H
Curr Neurovasc Res; 2010 Aug; 7(3):213-22. PubMed ID: 20560879
[TBL] [Abstract][Full Text] [Related]
13. Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats.
Lupachyk S; Watcho P; Shevalye H; Vareniuk I; Obrosov A; Obrosova IG; Yorek MA
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E396-404. PubMed ID: 23736542
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
Elias KA; Cronin MJ; Stewart TA; Carlsen RC
Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304
[TBL] [Abstract][Full Text] [Related]
15. Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice.
Ogihara T; Nakagawa T; Hayashi M; Koyanagi M; Yonezawa A; Omura T; Nakagawa S; Kitada N; Imai S; Matsubara K
J Pharmacol Sci; 2019 Dec; 141(4):131-138. PubMed ID: 31734027
[TBL] [Abstract][Full Text] [Related]
16. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
[TBL] [Abstract][Full Text] [Related]
17. Calcimimetic restores diabetic peripheral neuropathy by ameliorating apoptosis and improving autophagy.
Chung YC; Lim JH; Oh HM; Kim HW; Kim MY; Kim EN; Kim Y; Chang YS; Kim HW; Park CW
Cell Death Dis; 2018 Nov; 9(12):1163. PubMed ID: 30478254
[TBL] [Abstract][Full Text] [Related]
18. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
